The University Cancer Center Hamburg (UCCH) at the University Medical Center Hamburg-Eppendorf (UKE) and the Lungenclinic Grosshansdorf are joining forces to give lung cancer patients improved access to the latest therapies, a press release said Monday (January 7, 2019). The collaboration is part of the “National Network Genomic Medicine (nNGM) Lung Cancer” funded by the German Cancer Aid (Deutsche Krebshilfe) to make new therapeutic approaches available to all patients as swiftly and to advance research in the field.
“This co-operation allows us to contribute the special expertise in the treatment of lung cancer patients, which has distinguished the certified lung cancer centre of the Lungenclinic for years, even closer together with UCCH’s comprehensive research,” said Prof. Dr. Carsten Bokemeyer, Director of the University Cancer Centre Hamburg. The focus will be on optimising patient care in northern Germany.
Co-operation and exchange
Expertise and skills in the respective clinics are being pooled for the project. Prof. Dr. Sonja Loges, Head of the Personalized Oncology Division at UKE, noted: “As a co-operating partner, we are assuming a key role in bringing lung cancer patients from clinics and surgeries in northern Germany closer together.”
Sources and further information: www.uke.de